IMC Chicago’s Health Catalyst HCAT Stock Holding History

IMC Chicago’s Portfolio HCAT Stock Details HCAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$56K	Buy	28,163 +9,712	+53%	+$14K	﹤0.01%	6136
2026 Q1	$23.4K	Buy	+18,451	New	+$34.7K	﹤0.01%	5621

Other funds holding HCAT

FLAM

First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return

CDC Financial Chicago, Illinois $239M AUM

PVM

Palogic Value Management Dallas, Texas $304M AUM 15.15% 1-Year Est. Return

Impax Asset Management Group London, United Kingdom $15.4B AUM 26.43% 1-Year Est. Return

Nepsis Inc Minneapolis, Minnesota $295M AUM 35.44% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

IMC Chicago's HCAT Position: Q2 2026 in Review

IMC Chicago increased its Health Catalyst (HCAT) stake by 53% in Q2 2026, buying an estimated $14K and bringing the position to 28,163 shares worth $56K. The position accounts for ﹤0.01% of the portfolio, ranked #6136.

IMC Chicago first reported a position in HCAT in Q1 2026 and has held it in 2 quarters since. 127 funds tracked by Wall St. Rank hold HCAT as of Q2 2026.

IMC Chicago held 28,163 shares of Health Catalyst worth $56K as of Q2 2026.
IMC Chicago bought 9,712 Health Catalyst shares in Q2 2026, an estimated $14K.
Health Catalyst made up ﹤0.01% of IMC Chicago's portfolio in Q2 2026, its #6136 holding.
IMC Chicago first reported a position in Health Catalyst in Q1 2026 and has held it in 2 quarters since.
127 funds tracked by Wall St. Rank held Health Catalyst as of Q2 2026.

Based on IMC Chicago's 13F filing for Q2 2026, filed 6 Aug 2026.